Continue Reading
Full article on Yahoo Finance
Harvard Bioscience Announces Reverse Stock Split
Market Intelligence Analysis
AI-Powered
Why This Matters
Harvard Bioscience announced a 1-for-10 reverse stock split, effective March 16, 2026, which may increase the stock's value by reducing the number of outstanding shares, but may also make it less accessible to individual investors.
Market Impact
Market impact analysis based on bullish sentiment with 80% confidence.
Sentiment
Bullish
AI Confidence
80%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Harvard Bioscience’s common stock is expected to begin trading on a post-split adjusted basis on March 16, 2026 HOLLISTON, Mass., March 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a global leader in life science research tools, today announced that its board of directors approved the Company’s 1-for-10 reverse stock split (the “Reverse Split”) of the Company’s common stock, par value $0.01 per share. The Reverse Split was approved
Original article published by
Yahoo Finance
on March 7, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.